Table of contents

ORIGINAL ARTICLE

• Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer

  (1 June, 2005)

  J. J. Kavanagh, D. M. Gershenson, H. Choi, L. Lewis, K. Patel, G. L. Brown, A. Garcia, D. R. Spriggs
• Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging (1 June, 2005)

  M. Shimada, J. Kigawa, Y. Kanamori, H. Itamochi, T. Oishi, Y. Minagawa, K. Ishihara, Y. Takeuchi, M. Okada, N. Terakawa
• Stage IV ovarian cancer: a retrospective study on patient's management and outcome in a single institution (1 June, 2005)

  Y. Brunisholz, J. Miller, A. Proietto
• Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma (1 June, 2005)

  B. Piura, A. Rabinovich
• Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance (1 June, 2005)

  A. Ayhan, D. Ertunc, E. C. Tok, A. Ayhan
• Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer (1 June, 2005)

  E. J. Roos, M. A. Van Eijkeren, T. A. Boon, A. P.M. Heintz
• The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection (1 June, 2005)

  I. Ogino, H. Nakayama, T. Kitamura, N. Okamoto, T. Inoue
• Knowledge of cervical cancer and screening among women in east-central England (1 June, 2005)

  Z. Philips, M. Avis, D. K. Whynes
• Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study (1 June, 2005)

  S. Tangjitgamol, P. T. Ramirez, C. C. Sun, H. T. See, A. Jhingran, J. J. Kavanagh, M. T. Deavers
• Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger (1 June, 2005)

  T. Ota, M. Yoshida, M. Kimura, K. Kinoshita
• Expression of cellular FLICE/caspase-8 inhibitory protein is associated with malignant potential in endometrial carcinoma (1 June, 2005)

  H.-X. Chen, Y.-J. Liu, X.-D. Zhou, R.-Y. Luo